Hints and tips:
...Up until now, the PGA Tour has been a commercial animal, it has been incredibly successful,” says Steve Martin, chief executive of M&C Saatchi Sport & Entertainment....
...Firms like Lazard are desperate to woo C-suite executives as a means to eventually get those mandates....
...A January Forbes article named SBF as one of the group’s (then) billionaire backers....
...What’s missing is an integrated smartphone mount to aid with viewing the app, but you could add one yourself or wait for the V, which will include one....
...It is the latest salvo in the CMA’s long-running battle with the pharmaceutical groups over a record £84.2m fine that the watchdog levied against them in 2016, which Pfizer won an appeal against in 2018....
...After a long career in the pharmaceutical industry, Bruno Angelici may make his biggest mark selling an inhaler manufacturer to Big Tobacco....
...groups....
...And the UK-Swedish pharma group was working with Oxford university on the world’s leading vaccine candidate for Covid-19....
...This is a guest post by Steven Desmyter, Man Group’s co-head of responsible investing who argues that when it comes to the Covid-19 vaccine, it pays not to profit from disaster....
...Private equity-owned German pharmaceutical group Stada has attacked “protectionist” moves by the EU to shift medicine manufacturing to the bloc from Asia and says it will continue to source and sell globally...
...Shares in the California-based biotech group Gilead Sciences, which was at the centre of a political firestorm five years ago over a $1,000-a-day hepatitis C drug, are up 18 per cent after it became the...
...Gilead is not alone in turning to M&A to bolster its portfolio of cancer drugs....
...This increased source of repeat custom will have proven vital in what has been an unpredictable year for veterinary groups, which have been subject to restrictions on the practices they have been allowed...
...The pharmaceuticals group expects to have spun off the unnamed new company by the first half of 2021. Senior Merck executive Kevin Ali will lead the new group....
...If Taiwan and South Korea can graduate into roles vital to the tech supply chain, he said, “Why not Vietnam?”...
...A Telegram Markets Live chat group is also available....
...Here’s Goodbody: Cranswick provided a Q1 trading update this morning reporting a strong start to the year with c.19% LFL sales growth (25% inc. acquisitions)....
...It comes as Gilead is under pressure from sliding sales of its blockbuster hepatitis C drug, and is the first major move by chief executive Daniel O’Day who joined from Roche Pharmaceuticals in March....
...WPP will also reduce is planned capex from £400m to v£300m....
...“I expect the existing incumbents of Imperial, BAT and Japan Tobacco will need to revisit their playbooks for M&A and value creation,” he said....
...The ONS estimates the value of land and assets-over-land to be over £5tn compared to a GDP of c£2tn....
...That leaves GSK to focus on its pharmaceutical pipeline, silencing critics who worried Ms Walmsley would champion her old gaff over science....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...I’m working on a quarter that’ll happen in 2021 right now.”...
...Gilead’s $11.2bn purchase of Pharmasset, a hepatitis C biotech, in 2012, brought with it one of the most lucrative drug franchises....
International Edition